111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Update

111, Inc. Sponsored ADR (NASDAQ:YIGet Free Report) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totaling 35,430 shares, a growth of 2,235.5% from the December 31st total of 1,517 shares. Based on an average trading volume of 113,328 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.7% of the company’s stock are sold short. Currently, 0.7% of the company’s stock are sold short. Based on an average trading volume of 113,328 shares, the days-to-cover ratio is presently 0.3 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of 111 in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

View Our Latest Analysis on YI

111 Stock Performance

Shares of NASDAQ YI opened at $5.25 on Wednesday. The stock has a market cap of $45.36 million, a price-to-earnings ratio of -6.25 and a beta of 0.51. The business has a 50 day simple moving average of $3.80 and a 200 day simple moving average of $5.00. 111 has a 52 week low of $2.48 and a 52 week high of $11.35.

111 (NASDAQ:YIGet Free Report) last posted its earnings results on Wednesday, December 17th. The company reported ($1.20) EPS for the quarter. The business had revenue of $421.49 million for the quarter.

About 111

(Get Free Report)

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.

See Also

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.